Amgen’s big win – Amgen’s experimental denosumab is more effective than Novartis’ blockbuster Zometa in preventing advanced breast cancer from damaging bone, Amgen said in a pr… more →
Impactiviti blogkirbyghorton wrote 7 hours ago: As the cost of prescription medicine continues to increase, many Americans do not have adequate in … more →
afteramerica wrote 2 days ago: Stephen Lendman Global Research July 14, 2009 On July 13, a World Health Organization (WH … more →
kirbyghorton wrote 3 days ago: www.rxhelpforwa.org is a very helpful site for patients that live in the state of Washington and n … more →
Steve Woodruff wrote 1 week ago: Amgen’s big win – Amgen’s experimental denosumab is more effective than Novartis … more →
kinasepro wrote 2 weeks ago: It’s a Ph1 Aurora A/B/C inhibitor for ’solid tumors’. Seems likely to be a member … more →
sakerfa wrote 3 weeks ago: (Bloomberg) – Executives at U.S. companies are taking advantage of the biggest stock-market ra … more →
kirbyghorton wrote 1 month ago: I received so many emails from patients that are taking Enbrel and are having tremendous difficulty … more →
kirbyghorton wrote 1 month ago: Using a combination of disease-modifying antirheumatic drugs (DMARDs) rather than just one DMARD to … more →
silico wrote 1 month ago: Cytokinetics and Amgen today announced that Amgen has exercised its option to obtain an exclusive li … more →
Ellen wrote 1 month ago: I’m busy weeding, cleaning, cooking, shopping and spending time with my kids in Seattle so I … more →
kirbyghorton wrote 2 months ago: Medicare Part D has been a blessing for many seniors that are on a fixed income and have a limited b … more →
kinasepro wrote 2 months ago: As a comment in another thread notes, they have a handful of these too. The regioismer is the novel … more →
Steve Woodruff wrote 2 months ago: This will probably be the last Top Three post for about a week or so, as I head out to Chicago for t … more →
sakerfa wrote 2 months ago: (Bloomberg) – President Barack Obama proposed raising about $190 billion over the next decade … more →
Orlando wrote 2 months ago: So this story comes to an end… Or has it? One and a half years ago, 100 students ventured int … more →
efulke1785 wrote 2 months ago: We posted the full earnings analysis of Amgen Inc. (NASDAQ: AMGN), but one thing is becoming very cl … more →
Joshua M Brown wrote 2 months ago: The Reformed Broker, AKA Derick Sermon, here with today’s Market Recap… They loved … more →
kinasepro wrote 4 months ago: Here’s one where they do tell us why its off the pipeline: J Med Chem -> Chem Res Tox mak … more →
marshwhiteman wrote 4 months ago: Sarah Rubenstein, in her WSJ Health Blog (17 MAR 09) suggests that Roche and Genetech have very diff … more →